pamidronate has been researched along with cyclosporine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berguer, DG; Burckhardt, P; Goy, JJ; Krieg, MA; Sandini, L; Seydoux, C; ThiƩbaud, D | 1 |
Fassi, J; Plantalech, L | 1 |
Huynh, VM; Lai, LW; Lee, CT; Lien, YH | 1 |
Bradstock, K; Ebeling, PR; Grigg, AP; Herrmann, R; Hui, C; Reynolds, J; Schwarer, AP; Shuttleworth, P; Szer, J | 1 |
1 review(s) available for pamidronate and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pamidronate and cyclosporine
Article | Year |
---|---|
Pamidronate reduces bone loss after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Bone Density; Bone Remodeling; Cyclosporine; Diphosphonates; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteonecrosis; Osteoporosis; Pamidronate; Stem Cell Transplantation; Transplantation, Homologous | 2006 |
7 other study(ies) available for pamidronate and cyclosporine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.
Topics: Bone Density; Cyclosporine; Diphosphonates; Female; Glucocorticoids; Heart Transplantation; Humans; Male; Middle Aged; Osteoporosis; Pamidronate; Prospective Studies | 2001 |
[Vertebral osteoporosis induced by corticoids and cyclosporine ina a patient with Still disease].
Topics: Adrenal Cortex Hormones; Adult; Benzothiadiazines; Calcitonin; Cyclosporine; Diphosphonates; Diuretics; Female; Humans; Osteoporosis; Pamidronate; Sodium Chloride Symporter Inhibitors; Spinal Fractures; Still's Disease, Adult-Onset | 2001 |
Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice.
Topics: Animals; Anti-Inflammatory Agents; Bone Diseases, Metabolic; Calbindin 1; Calbindins; Calcium; Calcium Channels; Cyclosporine; Diphosphonates; Gene Expression; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Knockout; Pamidronate; S100 Calcium Binding Protein G | 2002 |